CHEMICAL/BIOLOGICAL DEFENSE (APPLIED RESEARCH)
Abstract
This Program Element (PE) sustains a robust defense program and core science and technology capabilities, which both reduces the danger of a Chemical, Biological, or Radiological (CBR) attack and enables U.S. forces to survive, and continue operations in a CBR environment. In the physical sciences area, Project CB2, focuses on continuing improvements in CB defense materiel, including contamination avoidance, decontamination, and protection technologies, as well as biological weapon/agent surveillance. The medical program, Project TM2, focuses on the development of antidotes, drug treatments, disease surveillance and point-of-need diagnostic devices, patient decontamination and medical technologies management. The program also provides for the Medical Countermeasures Initiative (MCMI), which was established to provide the capability for the advancement of regulatory science and flexible manufacturing of biological MCM to address CBR threats, including novel and previously unrecognized, naturally-occurring emerging infectious diseases. For Non-Traditional Agents (NTAs), Project NT2 consolidates all NTA efforts (both medical and non-medical) including pretreatments, therapeutics, detection, threat agent science, modeling, and protection and hazard mitigation. Efforts under this PE will transition to or will provide risk reduction for Advanced Technology Development (PE: 0603384BP), Advanced Component Development and Prototypes (PE: 0603884BP) and System Development and Demonstration (PE: 0604384BP).
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2015
- Source ID
- 0602384BP_2_0400_PB_2015
- Change Summary Explanation
- Funding: FY13: Reductions of $16.5M impacted the ability to advance potential solutions for sensing technologies, diagnostics, medical countermeasures, and toxin efforts. FY14: Reductions of $30.0M delay key physical and medical program applied research efforts in threat agent sciences, detection, algorithm development, protection, medical countermeasures, diagnostics, and hazard mitigation technology development. FY15: Reductions of $4.8M slow applied research efforts for medical countermeasures, diagnostic, and modeling efforts. Schedule: N/A Technical: N/A
- Service Agency Name
- Chemical and Biological Defense Program
Related Documents
- Child Project: CHEMICAL BIOLOGICAL DEFENSE (APPLIED RESEARCH)
- Child Accomplishment: 1) Biosurveillance
- Child Accomplishment: 2) Detection
- Child Accomplishment: 3) Warning and Reporting
- Child Accomplishment: 4) Hazard Prediction
- Child Accomplishment: 5) Data Analysis
- Child Accomplishment: 6) Operational Effects & Planning
- Child Accomplishment: 7) Filtration
- Child Accomplishment: 8) Respirator
- Child Accomplishment: 9) Lightweight Integrated Fabric
- Child Accomplishment: 10) Personnel Decontamination
- Child Accomplishment: 11) Decontamination
- Child Accomplishment: 12) Threat Agent Sciences
- Child Project: TECHBASE NON-TRADITIONAL AGENTS DEFENSE (APPLIED RESEARCH)
- Child Accomplishment: 1) Chemical Diagnostics - Medical
- Child Accomplishment: 2) Chemical Pretreatments - Medical
- Child Accomplishment: 3) Chemical Therapeutics - Medical
- Child Accomplishment: 4) Detection
- Child Accomplishment: 5) Modeling & Simulation
- Child Accomplishment: 6) Air Purification
- Child Accomplishment: 7) Respirator
- Child Accomplishment: 8) Percutaneous Protection
- Child Accomplishment: 9) Decontamination
- Child Accomplishment: 10) Threat Agent Sciences
- Child Project: TECHBASE MED DEFENSE (APPLIED RESEARCH)
- Child Accomplishment: 1) Techbase Med Defense - Diagnostics
- Child Accomplishment: 2) Chemical Diagnostics
- Child Accomplishment: 3) Diagnostic Assays
- Child Accomplishment: 4) Diagnostic Technologies
- Child Accomplishment: 5) Next Generation Diagnostics
- Child Accomplishment: 6) Medical Countermeasures Initiative
- Child Accomplishment: 7) Bacterial/Toxins Vaccines
- Child Accomplishment: 8) Vaccine Platforms and Research Tools
- Child Accomplishment: 9) Viral Therapeutics
- Child Accomplishment: 10) Bacterial Therapeutics
- Child Accomplishment: 11) Toxin Therapeutics
- Child Accomplishment: 12) Multiagent Medical Countermeasures
- Child Accomplishment: 13) Pretreatments, Nerve Agents
- Child Accomplishment: 14) Cutaneous/Ocular Therapeutics
- Child Accomplishment: 15) Chemical Therapeutics
- Child Accomplishment: 16) Radiation Countermeasures